HCC1395 Cells

The HCC1395 cell line is a model derived from a human basal-like breast cancer, a subtype often associated with triple-negative breast cancer (TNBC). This cell line is known for its high genetic complexity, which includes significant genomic instability and a notable mutation profile typical of aggressive breast cancers. Studies focusing on HCC1395 have identified a considerable number of somatic mutations and copy number variations, contributing to its classification as a representative model for TNBC research.

HCC1395 is especially relevant for exploring mechanisms underlying drug resistance and metastasis in basal-like breast cancers. One study highlighted the use of this cell line to evaluate the impact of silencing genes associated with cell migration, such as ZEB2, revealing that its downregulation could reduce the invasive potential of HCC1395. Additionally, this cell line’s mutation landscape often includes alterations in genes related to DNA damage response and cell cycle regulation, such as TP53, which is frequently mutated in basal-like breast cancers.

These characteristics make HCC1395 an important tool for preclinical studies that investigate new therapeutic strategies, including targeted and combination therapies aimed at overcoming resistance. By incorporating high-throughput sequencing and functional genomics approaches, researchers use HCC1395 to better understand TNBC pathophysiology, contributing to the development of more effective treatment regimens.